PureTech Health PLC
F:0VQ0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PureTech Health PLC
F:0VQ0
|
US |
|
Askul Corp
OTC:ASKLF
|
JP |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
SWB:MOH
|
FR |
|
B
|
BNP Paribas SA
MIL:BNP
|
FR |
|
O
|
ONWARD Medical NV
F:63E
|
NL |
|
S
|
STINAG Stuttgart Invest AG
SWB:STG
|
DE |
|
E.ON SE
F:EOAA
|
DE |
|
TOC Co Ltd
TSE:8841
|
JP |
|
E.ON SE
F:EOAN
|
DE |
|
U
|
Uniper SE
F:UN01
|
DE |
|
C
|
Cisco Systems Inc
XMUN:CIS
|
US |
|
Uniper SE
F:UN0
|
DE |
Wall St Price Targets
0VQ0 Price Targets Summary
PureTech Health PLC
According to Wall Street analysts, the average 1-year price target for
0VQ0 is 45.51 EUR with a low forecast of 28.27 EUR and a high forecast of 62.2 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0VQ0's stock price target?
Price Target
45.51
EUR
According to Wall Street analysts, the average 1-year price target for
0VQ0 is 45.51 EUR with a low forecast of 28.27 EUR and a high forecast of 62.2 EUR.
What is the Revenue forecast for PureTech Health PLC?
Projected CAGR
97%
Over the last 12 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 97%.